Skip to main content

Table 5 Mean values in physiological and behavioural outcomes assessed at baseline and follow-up assessments for intervention and control groups and a comparison of the differences in the change between groups

From: Electrically assisted cycling for individuals with type 2 diabetes mellitus: a pilot randomized controlled trial

Outcome

Experimental

Control

Difference in change (CI)

  

Pre

Post

Change

 

Pre

Post

Change

 
 

N

Mean (CI)

Mean (CI)

Mean (CI)

N

Mean (CI)

Mean (CI)

Mean (CI)

Cardiorespiratory fitness

 Absolute VO2max, L/min

9a

1.82 (1.34, 2.30)

1.98 (1.35, 2.61)

0.16 (− 0.06, 0.41)

14

2.28 (2.03, 2.53)

2.34 (2.00, 2.67)

0.06 (− 0.11, 0.23)

 − 0.10 (− 0.39, 0.18)

 Relative VO2max, L/kg/min

9a

19.52 (15.30, 23.75)

21.61 (16.17, 27.04)

2.08 (− 0.86, 5.02)

14

23.07 (20.67, 25.46)

23.50 (21.43, 25.57)

0.43 (− 1.13, 2.00)

 − 1.65 (− 4.82, 1.51)

 Maximum power output, Watts

9a

147.99 (110.14, 185.84)

163.91 (112.70, 215.13)

15.92 (− 5.15, 36.99)

14

188.68 (172.95, 204.41)

181.96 (164.91, 199.01)

 − 6.72 (− 13.34, − 0.11)

 − 22.65 (− 44.17, − 1.12)

Body composition

 Body fat, %

13

34.03 (28.28, 39.78)

33.79 (28.11, 39.48)

 − 0.24 (− 0.99, 0.52)

16b

33.63 (29.82, 37.42)

33.24 (29.46, 37.02)

 − 0.38 (− 1.34, 0.57)

 − 0.14 (− 1.35, 1.07)

 Fat mass, kg

13

32.4 (24.91, 40.00)

31.28 (24.34, 38.22)

 − 1.18 (− 2.65, 0.30)

16b

33.73 (24.91, 40.00)

32.96 (26.48, 39.44)

 − 0.77 (− 2.20, 0.65)

0.40 (− 1.57, 2.38)

 Trunk fat mass, kg

13

17.79 (13.52, 22.06)

17.13 (13.19, 21.07)

 − 0.66 (− 1.46, 0.14)

16b

19.12 (15.15, 23.06)

18.64 (14.82, 22.47)

 − 0.47 (− 1.29, 0.36)

0.20 (− 0.92, 1.31)

 Leg fat mass, kg

13

5.03 (3.77, 6.28)

4.86 (3.63, 6.08)

 − 0.17 (− 0.41, 0.07)

16b

5.10 (3.97, 6.24)

5.02 (3.94, 6.09)

 − 0.09 (− 0.31, − 0.14)

0.08 (− 0.23, 0.40)

 Lean mass, kg

13

58.78 (50.98, 66.59)

57.54 (49.98, 65.10)

 − 1.24 (− 2.18, − 0.31)

16b

61.58 (54.53, 68.62)

61.52 (54.33, 68.71)

 − 0.05 (− 1.21, 1.10)

1.19 (− 0.28, 2.66)

 Leg lean mass, kg

13

10.27 (8.79, 11.75)

10.09 (8.65, 11.54)

 − 0.17 (− 0.30, − 0.04)

16b

11.00 (9.49, 12.51)

10.97 (9.51, 12.46)

 − 0.01 (− 0.21, 0.19)

0.16 (− 0.08, 0.40)

 pQCT femur mCSA, cm2

12

104.63 (88.50, 120.75)

101.87 (85.94, 117.81)

 − 2.76 (− 6.79, 1.28)

14

121.20 (105.66, 136.73)

119.99 (104.85, 135.12)

 − 1.01 (− 3.64, 1.62)

1.75 (− 2.64, 6.13)

 pQCT femur density, mg/cm3

12

61.63 (57.54, 65.71)

61.56 (57.25, 65.87)

 − 0.07 (− 1.10, 0.97)

14

61.78 (58.06, 65.50)

62.44 (59.37, 65.52)

 − 0.03 (− 1.78, 1.72)

0.04 (− 2.09, 2.17)

 pQCT IMAT area, cm2

12

19.99 (15.35, 24.63)

19.25 (14.86, 23.65)

 − 0.74 (− 1.09, 0.43)

14

23.94 (16.98, 30.90)

22.46 (17.64, 27.28)

 − 0.75 (− 3.48, 1.98)

 − 0.01 (− 3.20, 3.18)

 pQCT SAT area, cm2

12

48.97 (30.24, 67.70)

46.18 (27.08, 65.28)

 − 2.79 (− 5.47, − 0.12)

14

41.62 (25.94, 57.31)

41.97 (25.50, 58.45)

0.01 (− 2.34, 2.36)

2.8 (− 0.60, 6.20)

Physical activity

 Daily MVPA, minutes

11

49.12 (25.12, 73.11)

51.65 (24.82, 78.48)

2.53 (− 12.10, 17.16)

15

46.72 (33.39, 60.05)

42.77 (26.93, 58.62)

 − 3.95 (− 15.85, 7.95)

 − 6.91 (− 15.17, 1.35)

 Weekly MVPA, minutes

11

343.83 (175.86, 511.79)

361.55 (173.72, 549.37)

17.72 (− 84.72, 120.15)

15

327.06 (233.75, 420.38)

299.42 (188.53, 410.31)

 − 27.64 (− 110.94, 55.66)

 − 45.36 (− 170.33, 79.61)

  1. CI confidence interval, IMAT intramuscular adipose tissue, mCSA muscle cross-sectional area, MVPA moderate to vigorous physical activity, pQCT peripheral quantitative computer tomography, SAT subcutaneous adipose tissue, VO2max maximum oxygen uptake
  2. aOne participant removed have was told to restrain from exercise for 5 weeks during e-bike intervention due to exploratory surgery. bOne participant removed as had a gastric band